Enterovirus vaccine to become available in 2020
Infections with Enteroviruses are common in the United States during summer and fall. During that time in 2014, the United States experienced a nationwide outbreak of EV-D68 associated with severe respiratory illness. Researchers explain that Enteroviruses are one of the commonest infection leading to both acute as well as chronic infections, most of these infections are mild but if the virus affect the CNS, the infection can get sever. Polioviruses are the example of Enteroviruses. In 9 out of 10 infected persons there may be mild or no symptoms of the infection.
According to the European centre for disease prevention and control, way of infection spread via secretions from infected persons including saliva mucus sputum or feces. Childrens are most vulnerable to this infection and persons with a risk of complications with this infection include those who are young, pregnant, or immunocompromised. Vaccine to be 90% effective against serotype EV71. Taiwan will introduce an indigenously developed vaccine against Enterovirus next year 2020. However the island still needs to make efforts to produce a vaccine to counter EV 68, another strain that poses a threat to public health. A series of three shots is recommended for infants at 2 months, 4 months and 1 year old is order to ensure complete immunity against EV 71for 5 years.